Neramexane modified release matrix tablet
Details for Australian Patent Application No. 2006319411 (hide)
International Classifications
Event Publications
22 May 2008 PCT application entered the National Phase
PCT publication WO2007/062815 Priority application(s): WO2007/062815
16 September 2010 Application Accepted
Published as AU-B-2006319411
21 October 2010 Corrigenda
Applications Accepted - Name Index Under the name Merz Pharma GmbH & Co. KgaA, Application No. 2006319411, under INID (71) correct the applicant name to Merz Pharma GmbH & Co. KGaA
20 January 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006319415-Multimeric complexes of antigens and an adjuvant
2006319401-3-(substituted amino)-pyrazolo[3,4-d]pyrimidines as EphB and VEGFR2 kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser